Then why the fuck hasn't the US just added it to Medicare / Medicaid coverage? It makes no sense. These healthcare schemes are costly, and covering this medication would make it... less costly.
What does "less muscle-mass" mean in terms of mortality statistics?
We already know women live longer than men on average, and also have less muscle-mass than men on average, so clearly it's not having too much of an impact on women.
Without looking into actual statistics here, Japan is known for having a high life expectancy, and stereotypically Japan's population is both relatively thin, and has relatively little muscle, so that also seems to defy that expectation.
And specifically GLP-1 usage is associated with significant loss of lean mass:
https://pubmed.ncbi.nlm.nih.gov/38937282/
In some studies, reductions in lean mass range between 40% and 60% as a proportion of total weight lost ...
This might be a good start. There is quite a bit of material here and as might be expected much of it is fairly recent and gets a lot of this kind of skinny equals long life feedback that isn't strongly supported by clinical data.